Fabio
5.3 KiB
5.3 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Opioids; providers of treatment for addiction, conditions for initial licensure, location. | Providers of treatment for persons with opiate addiction; elimination of location restriction. Eliminates the requirement that a provider of treatment for persons with opiate addiction through the use of (i) methadone or (ii) opioid replacements other than opioid replacements approved for the treatment of opioid addiction by the U.S. Food and Drug Administration be located more than one-half mile from a public or private licensed day care center or a public or private K-12 school. This bill has a delayed effective date of January 1, 2023, and is identical to SB 300. | us/states/va | Virginia General Assembly | 2022 | HB 679 | Virginia HB 679 (2022) |
|
enacted |
|
4 | 28 | 6 | 2022-01-11 | 2022-04-11 | openstates | ocd-bill/ba93a571-fcc9-40d3-a042-c3d0c3df03d3 | https://lis.virginia.gov/cgi-bin/legp604.exe?221+sum+HB679 | 362747018bb4c9acad4588ca7c27ab67e3ba2383be43bd340bee1e43f1530e14 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Virginia HB 679 (2022) — Opioids; providers of treatment for addiction, conditions for initial licensure, location.
Providers of treatment for persons with opiate addiction; elimination of location restriction. Eliminates the requirement that a provider of treatment for persons with opiate addiction through the use of (i) methadone or (ii) opioid replacements other than opioid replacements approved for the treatment of opioid addiction by the U.S. Food and Drug Administration be located more than one-half mile from a public or private licensed day care center or a public or private K-12 school. This bill has a delayed effective date of January 1, 2023, and is identical to SB 300.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- CHAP0512 (committee substitute) — source
- HB679ER (committee substitute) — source
- Prefiled and ordered printed; offered 01/12/22 22101664D (committee substitute) — source
- Printed as engrossed 22101664D-E (committee substitute) — source
Votes
- VOTE: Block Vote Passage (99-Y 0-N) — 98–0 (pass) · lower
- Passed Senate (40-Y 0-N) — 40–0 (pass) · upper
- Reported from Health, Welfare and Institutions with amendment(s) (21-Y 0-N) — 21–0 (pass) · lower
- Subcommittee recommends reporting with amendments (9-Y 0-N) — 9–0 (pass) · lower
- Reported from Education and Health (15-Y 0-N) — 15–0 (pass) · upper
- Constitutional reading dispensed (39-Y 0-N) — 39–0 (pass) · upper
Sponsors
- Patrick A. Hope — primary (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2022-01-11 Prefiled and ordered printed; offered 01/12/22 22101664D
introduction - 2022-01-11 Referred to Committee on Health, Welfare and Institutions
referral-committee - 2022-01-21 Assigned HWI sub: Subcommittee #1
referral-committee - 2022-01-24 Impact statement from DPB (HB679)
- 2022-02-01 House subcommittee amendments and substitutes offered
- 2022-02-01 Subcommittee recommends reporting with amendments (9-Y 0-N)
- 2022-02-03 Reported from Health, Welfare and Institutions with amendment(s) (21-Y 0-N)
committee-passage - 2022-02-07 Read first time
reading-1 - 2022-02-08 Read second time
reading-2 - 2022-02-08 Committee amendments agreed to
- 2022-02-08 Engrossed by House as amended HB679E
- 2022-02-08 Printed as engrossed 22101664D-E
- 2022-02-09 Impact statement from DPB (HB679E)
- 2022-02-09 Read third time and passed House BLOCK VOTE (99-Y 0-N)
passage, reading-3 - 2022-02-09 VOTE: Block Vote Passage (99-Y 0-N)
- 2022-02-10 Constitutional reading dispensed
- 2022-02-10 Referred to Committee on Education and Health
referral-committee - 2022-02-24 Reported from Education and Health (15-Y 0-N)
committee-passage - 2022-02-25 Constitutional reading dispensed (39-Y 0-N)
- 2022-02-28 Read third time
reading-3 - 2022-02-28 Passed Senate (40-Y 0-N)
passage - 2022-03-03 Enrolled
- 2022-03-03 Signed by Speaker
- 2022-03-04 Signed by President
- 2022-03-10 Impact statement from DPB (HB679ER)
- 2022-03-11 Enrolled Bill communicated to Governor on March 11, 2022
- 2022-03-11 Governor's Action Deadline 11:59 p.m., April 11, 2022
- 2022-04-11 Approved by Governor-Chapter 512 (effective 1/1/23)
executive-signature
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/ba93a571-fcc9-40d3-a042-c3d0c3df03d3. Confidence: reported (aggregated from official Virginia legislature records).